Business Standard
Sunday, May 27, 2012
Sponsored by  
drived banner
drived banner
  Advanced Search
RSS
Content Guide
Follow us on  
||||Economy & Policy||||| 
 Section Home | News Now | Today's Paper | Features & Analysis | Politics & Public Affairs | Q&A | Columnists | BS Says
Home > Economy & Policy Live Markets | Commodities
 

China seeks to enter finished drug biz in India
BS Reporter / New Delhi Dec 16, 2010, 01:03 IST

After establishing its dominance in the export of bulk drugs (raw materials for medicine production) to India, the Chinese drug industry is exploring ways to enter the final frontier in drug production — the finished goods or formulation business — in the country.

A 12-member team of pharmaceutical industry representatives, who are part of the visiting Chinese delegation, said entering India’s formulation market would be one of their major objectives. The team is also open for collaborations with domestic drug makers to participate in global medicine supply tenders.

“We have huge API (bulk drug) exports to India. China’s engagement with India in the medicine sector in revenue terms has been $3.1 billion (over Rs 14,000 crore) during the first 10 months of 2010. It was $2.8 billion (over Rs 12,600 crore) in 2009. The bulk of this business came from the sale of raw materials, not formulations,” said Liu Zhanglin, vice-president of the China Chamber of Commerce for Import and Export of Medicines and Health Products.

Liu said Chinese drug makers were open to regulatory inspections by Indian authorities.

Daara Patel, secretary general of the Indian Drug Manufacturers’ Association (IDMA), said the domestic pharmaceutical industry would be willing to enter into long-term partnerships with Chinese firms wherever there was a win-win situation. “The Chinese are known for their bulk drug manufacturing capabilities. Indian formulation companies, which source their raw material requirements from China, can partner with them while applying for global supply tenders,” Patel said.

According to Patel, Idma and its Chinese counterpart — Chinese Pharmaceutical Industries Association — will sign a memorandum of understanding (MoU) for long-term cooperation in the areas of registration, importation, distribution, marketing and administration of drugs and medicines on January 7, 2011.

Meanwhile, the Chinese chamber has already signed an MoU with the Federation of Indian Chambers of Commerce and Industry to promote exchange, cooperation and trade.

New Ipad Application :Business Standard's all new IPad App
Click here to download for free
Arrow Other Stories     
- Markets end flat
- China's new privatisation plan faces push-back risk
- New Delhi seeks stronger Myanmar ties as PM visits
- India to guarantee safe gas transit from Tapi
- Pak players likely to be part of IPL 2013
  Read Business news in 
- Journey on, We are by Your Side. Click here to know more
- Benefits Upto Rs. 2.36 Lakhs on the Fully Loaded TJet Petrol.
- The Best Seller is Also the No. 1 in Mileage. Click here
- Watch The Film Here. Click here to know more..
- Leader in Passenger Car & Automobile Tyres. Click here
- 1 billion in saving for Unilever without any tangles.
- Learn How One City is Running on FOOD SCRAPS.
- One Partnership Endless Possibilities. Click here to know more
- Helping doctors detect diseases earlier, saving costs & extending lives.
- 36 Lakhs can get you a pool of Luxuries. Click here
- Which is the best plan for your daughter
- Check out the TRUE COLOURS of your Stocks, Now for FREE!
- One of the leading business schools in the world.Know More
Sorry, comments to this story are closed
Latest Messages
Table for Two
  Now available at Special price
  Rs.280/- Only

  Buy Now
BS POLL
UPA 2 has completed three years. How do you rate its performance?  Read the story
  Good
  Average
  Bad
Submit
Most Popular
Read
E-Mailed
Commented
   
- EGoM to now decide on base price for spectrum auction
- Air India pilots wanted a halt to command training of IA pilots
- Rohit Viswanath: The news about soft power
- New power equation in BJP
- Traders go long on $-Re , short on Euro-Re
 
 More  
New Ipad Application
 Business Standard's all new IPad  App
 Click here to download for free
  Hot Searches  
 
Apalya |  Air India |  GAAR |  Agni  |  Solar eclipse |  Satyamev Jayate |  SRK |  Aamir Khan |  IPL |  Ertiga |  Sarfaesi Act |  Vodafone |  JP Morgan |  Transfer pricing |  Rupee |  Kingfisher Airlines |  Silver |  Provident Fund |  income tax refund |  iPhone |  Reliance Industries |  SEBI |  BSNL |  BSE |  NSE |  Mukesh Ambani |  Anil Ambani |  Infosys |  Pranab Mukherjee |  Sonia Gandhi |  Rahul Gandhi |  New Pension Scheme |  Reliance |  RBI |  GDP |  Gold |  Ratan Tata |  ICICI |  B-School |  Sensex |  Tax calculator |  Home Loan |  Personal Finance |  inflation |  oil prices |  Barack Obama |   
 
  Member Area Write to the Editor RSS Archives Advanced Search
  Subscribe to BS print product BS e-paper Newsletter Portfolio Tracker
  BS Products BS Hindi BS Motoring BS Books
Home | Markets & Investing | Companies & Industry | Banking & Finance | Economy & Policy | Opinion
Life & Leisure | Management & Marketing | Tech World | General News
About Us | Partner With Us | Code of Conduct | Careers | Advertise with us| Terms & Conditions | Disclaimer | Contact Us